Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Amyndas Pharmaceuticals S.A.

Headquarters: Glyfada, Greece
Year Founded: 2013
Status: Private

BioCentury | Feb 8, 2023
Data Byte

Competition heats up in PNH with new Roche data

A dozen complement inhibitors behind Roche’s crovalimab also hope to challenge established therapies
BioCentury | Aug 11, 2017
Regulation

Foundation for inclusion

How the National Kidney Foundation is driving patient-centric R&D
BioCentury | Feb 10, 2014
Emerging Company Profile

Amyndas: Complement shutdown

Amyndas developing super compstatins for complement-mediated disorders
Items per page:
1 - 5 of 5